← Back to Analyst Consensus 
ORA Buy
ORMAT TECHNOLOGIES, INC.
Current Price —
Implied Upside —
Analysts 17
30-Day Momentum
▲ 0 upgrades / ▼ 1 downgrades / 1 reiterations from 2 firms
Next Earnings
Nov 4, 2026 (9 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 19, 2026 | JP Morgan | maintain | Neutral → Neutral | — | 55% |
| Oct 1, 2026 | UBS | downgrade | Buy → Neutral | — | 54% |
| Sep 9, 2026 | JP Morgan | maintain | Neutral → Neutral | — | 55% |
| Sep 9, 2026 | Oppenheimer | maintain | Outperform → Outperform | — | 52% |
| Sep 9, 2026 | RBC Capital | reiterate | Outperform → Outperform | — | 55% |
| Sep 4, 2026 | Bernstein | upgrade | Underperform → Market Perform | — | 52% |
| Aug 10, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Aug 7, 2026 | Oppenheimer | maintain | Outperform → Outperform | — | 52% |
| Jul 16, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Jun 17, 2026 | Bernstein | initiate | — → Underperform | — | 52% |
| May 18, 2026 | Piper Sandler | maintain | Overweight → Overweight | — | 54% |
| May 8, 2026 | UBS | maintain | Buy → Buy | — | 54% |
| May 8, 2026 | JP Morgan | maintain | Neutral → Neutral | — | 55% |
| May 8, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Apr 16, 2026 | JP Morgan | maintain | Neutral → Neutral | — | 55% |
| Mar 3, 2026 | UBS | maintain | Buy → Buy | — | 54% |
| Mar 3, 2026 | RBC Capital | initiate | — → Outperform | — | 55% |
| Mar 2, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Feb 27, 2026 | Baird | maintain | Outperform → Outperform | $130 | 55% |
| Feb 18, 2026 | Citigroup | maintain | Neutral → Neutral | $128 | 54% |
| Feb 13, 2026 | Jefferies | downgrade | Buy → Hold | $130 | 52% |
| Jan 27, 2026 | Oppenheimer | maintain | Outperform → Outperform | $136 | 52% |
| Jan 15, 2026 | Barclays | maintain | Overweight → Overweight | $108 | 53% |
| Jan 9, 2026 | TD Cowen | upgrade | Hold → Buy | $130 | 54% |
| Dec 18, 2025 | Piper Sandler | maintain | Overweight → Overweight | $125 | 54% |
| Nov 7, 2025 | UBS | maintain | Buy → Buy | $135 | 54% |
| Nov 7, 2025 | Barclays | maintain | Overweight → Overweight | $118 | 53% |
| Nov 5, 2025 | JP Morgan | maintain | Neutral → Neutral | $111 | 55% |
| Nov 5, 2025 | TD Cowen | maintain | Hold → Hold | $100 | 54% |
| Nov 5, 2025 | Roth Capital | reiterate | Buy → Buy | $125 | 53% |
| Oct 16, 2025 | JP Morgan | maintain | Neutral → Neutral | $99 | 55% |
| Oct 7, 2025 | Jefferies | maintain | Buy → Buy | $120 | 52% |
| Sep 17, 2025 | Piper Sandler | upgrade | Neutral → Overweight | $102 | 54% |
| Aug 19, 2025 | Piper Sandler | maintain | Neutral → Neutral | $90 | 54% |
| Aug 8, 2025 | Barclays | maintain | Overweight → Overweight | $89 | 53% |
| Aug 5, 2025 | Roth Capital | reiterate | Buy → Buy | $98 | 53% |
| Jul 30, 2025 | Baird | upgrade | Neutral → Outperform | $103 | 55% |
| Jul 24, 2025 | UBS | maintain | Buy → Buy | $105 | 54% |
| Jul 22, 2025 | JP Morgan | maintain | Neutral → Neutral | $85 | 55% |
| Jul 10, 2025 | Barclays | maintain | Overweight → Overweight | $90 | 53% |
| Jun 6, 2025 | Barclays | upgrade | Equal-Weight → Overweight | $86 | 53% |
| May 8, 2025 | Barclays | maintain | Equal-Weight → Equal-Weight | $80 | 53% |
| Mar 25, 2025 | Jefferies | maintain | Buy → Buy | $86 | 52% |
| Mar 13, 2025 | Baird | initiate | — → Neutral | $81 | 55% |
| Feb 28, 2025 | JP Morgan | maintain | Neutral → Neutral | $75 | 55% |
| Feb 20, 2025 | Jefferies | upgrade | Hold → Buy | $78 | 52% |
| Jan 10, 2025 | Jefferies | initiate | — → Hold | $73 | 52% |
| Dec 19, 2024 | Piper Sandler | initiate | — → Neutral | $78 | 54% |
| Nov 8, 2024 | Roth MKM | reiterate | Buy → Buy | $92 | 52% |
| Nov 8, 2024 | Oppenheimer | maintain | Outperform → Outperform | $91 | 52% |
Price Target Trend
Mar 26, 2026 Oct 26, 2026
EPS Estimates
0y —
+1y —
+1q —
0q —
Cross-Platform Signals
No cross-platform signals in the last 90 days